Ads
related to: latest developments in cancer research articles journal submission
Search results
Results From The WOW.Com Content Network
The annual ESMO Congress is attended by 30,000 participants. The congress presents the latest scientific developments in basic, translational and clinical cancer research and contextualises new findings for practical implementation in every day patient care.
Cancer Cell is internationally regarded as one of the top cancer research and oncology journals. According to the Journal Citation Reports, the 2022 impact factor of the journal is 50.3. It is part of the Cell Press portfolio, which is owned by Elsevier. Issues are published monthly in print and online versions.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics.
The American Journal of Cancer Research is a medical journal established in 2011. [3] It covers all areas of clinical oncology and experimental cancer research and publishes review articles, original articles, and editorials. It is published by e-Century Publishing Corporation.
It covers research on all aspects of cancer and cancer-related biomedical sciences and was established in 1941. The editor-in-chief is Chi Van Dang. [1] The journal was established in 1916 as the Journal of Cancer Research, was renamed American Journal of Cancer in 1931, and obtained its current name in 1941.
It publishes original research articles, mini reviews, short reports, and letters to the editor. The journal was established in 1966 and is published by John Wiley & Sons on behalf of the Union for International Cancer Control. The editor-in-chief is Christoph Plass (Deutsches Krebsforschungszentrum).
Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research. The journal is published by BioMed Central and was established in 2002. The first editor-in-chief was Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research . [ 1 ]
Cancer and Metastasis Reviews is a quarterly peer-reviewed medical review journal covering oncology and the development of new cancer treatments. It was established in 1982 and is published by Springer Science+Business Media .